Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 923,258
  • Shares Outstanding, K 339,433
  • Annual Sales, $ 792,320 K
  • Annual Income, $ 16,390 K
  • EBIT $ 164 M
  • EBITDA $ 236 M
  • 60-Month Beta 1.47
  • Price/Sales 1.16
  • Price/Cash Flow 8.64
  • Price/Book 1.55

Options Overview Details

View History
  • Implied Volatility 101.44% (+17.38%)
  • Historical Volatility 32.98%
  • IV Percentile 80%
  • IV Rank 46.76%
  • IV High 157.81% on 10/29/25
  • IV Low 51.94% on 12/09/24
  • Expected Move (DTE 10) 0.43 (15.62%)
  • Put/Call Vol Ratio 0.34
  • Today's Volume 539
  • Volume Avg (30-Day) 1,343
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 75,703
  • Open Int (30-Day) 82,322
  • Expected Range 2.30 to 3.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 3
  • High Estimate 0.06
  • Low Estimate 0.04
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.61 +2.70%
on 11/21/25
3.13 -14.36%
on 11/10/25
-0.43 (-13.81%)
since 11/07/25
3-Month
2.61 +2.70%
on 11/21/25
5.81 -53.86%
on 10/09/25
-1.45 (-35.09%)
since 09/09/25
52-Week
2.61 +2.70%
on 11/21/25
5.81 -53.86%
on 10/09/25
-2.28 (-45.96%)
since 12/09/24

Most Recent Stories

More News
1 Profitable Stock Worth Your Attention and 2 We Turn Down

1 Profitable Stock Worth Your Attention and 2 We Turn Down

GDRX : 2.68 (-1.45%)
MU : 244.38 (-1.03%)
LW : 59.53 (-0.28%)
Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

NTRA : 239.14 (-2.21%)
TECH : 60.29 (-2.25%)
GDRX : 2.68 (-1.45%)
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

UFPT : 215.79 (-0.62%)
GDRX : 2.68 (-1.45%)
MASI : 140.85 (-0.59%)
MRNA : 27.74 (-0.82%)
CLOV : 2.56 (unch)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

MMSI : 83.11 (-0.38%)
GDRX : 2.68 (-1.45%)
ALGM : 28.86 (+0.38%)
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment

GDRX : 2.68 (-1.45%)
5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call

5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call

GDRX : 2.68 (-1.45%)
3 Value Stocks We Find Risky

3 Value Stocks We Find Risky

GDRX : 2.68 (-1.45%)
BEN : 23.12 (-1.20%)
AMRX : 11.92 (+0.42%)
3 Low-Volatility Stocks with Open Questions

3 Low-Volatility Stocks with Open Questions

GDRX : 2.68 (-1.45%)
COO : 78.16 (+0.16%)
GES : 16.92 (-0.41%)
GDRX Q3 Deep Dive: Manufacturer Solutions Growth Offsets Flat Prescription Volumes

GDRX Q3 Deep Dive: Manufacturer Solutions Growth Offsets Flat Prescription Volumes

GDRX : 2.68 (-1.45%)
GoodRx’s (NASDAQ:GDRX) Q3 Sales Top Estimates

GoodRx’s (NASDAQ:GDRX) Q3 Sales Top Estimates

GDRX : 2.68 (-1.45%)

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 2.82
2nd Resistance Point 2.79
1st Resistance Point 2.76
Last Price 2.68
1st Support Level 2.69
2nd Support Level 2.66
3rd Support Level 2.63

See More

52-Week High 5.81
Fibonacci 61.8% 4.59
Fibonacci 50% 4.21
Fibonacci 38.2% 3.83
Last Price 2.68
52-Week Low 2.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar